Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Safe Supply Announces Proposed Acquisition of European Medical Testing Subsidiary (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Imunon Inc IMNN

Healthcare Biotechnology
Imunon, Inc. is a clinical-stage biotechnology company. The Company is focused on advancing a portfolio of treatments that harness the body’s natural mechanisms across an array of human diseases. The Company is developing non-viral Deoxyribonucleic acid (DNA) technology across four modalities. The first modality, TheraPlas, is developed for the coding of proteins and cytokines in the treatment... see more

Recent & Breaking News (NDAQ:IMNN)

22 Stocks Moving In Friday's Pre-Market Session

Benzinga.com  June 16, 2017

A Peek Into The Markets: U.S. Stock Futures Up Ahead Of Housing Starts, Consumer Sentiment Data

Benzinga.com  June 16, 2017

Celsion Corporation Regains Compliance with NASDAQ Listing Requirements

GlobeNewswire June 14, 2017

11 Biggest Mid-Day Losers For Tuesday

Benzinga.com  June 6, 2017

22 Stocks Moving In Tuesday's Pre-Market Session

Benzinga.com  June 6, 2017

Celsion Announces Presentation of OVATION Study Findings at the ASCO 2017 Annual Meeting

GlobeNewswire June 5, 2017

Celsion Corporation Announces Stock Consolidation

GlobeNewswire May 26, 2017

Investor Network: Celsion Corporation to Host Earnings Call

Accesswire May 12, 2017

Celsion Corporation Reports First Quarter 2017 Financial Results and Provides Business Update

GlobeNewswire May 12, 2017

Technical Reports on Biotech Stocks -- Celsion, Incyte, ImmunoGen, and Catabasis Pharma

PR Newswire May 11, 2017

Celsion Corporation to Hold First Quarter 2017 Financial Results Conference Call on Friday, May 12, 2017

GlobeNewswire May 5, 2017

Celsion Updates Clinical Data from the OVATION Study in Newly Diagnosed  Advanced Ovarian Cancer Patients

GlobeNewswire May 4, 2017

Celsion Announces Presentation of OVATION Study Findings at the Upcoming ASCO 2017 Annual Meeting

GlobeNewswire April 20, 2017

Celsion Corporation Reports Preclinical Results of ThermoDox® for the Treatment of Bladder Cancer Published in the International Journal of Hyperthermia

GlobeNewswire April 13, 2017

Biotech Stocks Under Scanner -- Celsion, Achillion Pharma, Tenax Therapeutics, and Cerulean Pharma

PR Newswire March 29, 2017

Celsion Corporation Reports Year End 2016 Financial Results and Provides Business Update

GlobeNewswire March 16, 2017

Celsion Corporation to Hold Year-End 2016 Financial Results Conference Call on Thursday, March 16, 2017

GlobeNewswire March 9, 2017

Celsion Presents Two Posters on its GEN-1 IL-12 Gene-Mediated Immunotherapy at the ASCO-SITC Clinical Immuno-Oncology Symposium

GlobeNewswire February 27, 2017

Celsion Corporation Announces $5.0 Million Public Offering

GlobeNewswire February 15, 2017

Celsion to Present Two Posters on its GEN-1 IL-12 Gene-Mediated Immunotherapy at the ASCO-SITC Clinical Immuno-Oncology Symposium

GlobeNewswire January 19, 2017